Table 2.
VA-EPS: [ABCD]n | DP4: AnrBCr′Dr | DP8: AnrBCDABCr′Dr | |
---|---|---|---|
A1: 6Ala-GalA/A2:6Ser-GalA | |||
H1 | 5.18/5.19 | 5.20/5.20 | |
H2 | 3.84/3.84 | 3.80/3.80 | |
H3 | 4.00/4.00 | 4.04/4.04 | |
H4 | 4.49/4.51 | 4.54/4.54 | |
H5 | 4.91/4.96 | 4.99/5.04 | |
A1nr: 6Ala-GalA/A2nr:6Ser-GalA | |||
H1 | 5.22/5.23 | 5.20/5.22 | |
H2 | 3.78/3.78 | 3.80/3.80 | |
H3 | 3.97/3.99 | 3.99/3.99 | |
H4 | 4.33/4.36 | 4.34/4.34 | |
H5 | 4.99/5.04 | 4.99/5.04 | |
B: GalA | |||
H1 | 5.22 | 5.22 | 5.23 |
H2 | 3.93 | 3.93 | 3.95 |
H3 | 4.10 | 4.14 | 4.15 |
H4 | 4.51 | 4.52 | 4.53 |
H5 | 4.58 | 4.64 | 4.65 |
C: 6Ala-GalA | |||
H1 | 5.43 | 5.50 | |
H2 | 3.97 | 3.98 | |
H3 | 4.03 | 4.02 | |
H4 | 4.48 | 4.50 | |
H5 | 4.31 | 4.32 | |
Cr′: 6Ala-GalA | |||
H1-Dr α/β | 5.48/5.51 | 5.48/5.51 | |
H2-Dr α/β | 3.98/3.97 | 3.98/3.97 | |
H3-Dr α/β | 4.02/4.00 | 4.03/4.00 | |
H4 | 4.50 | 4.50 | |
H5 | 4.31 | 4.32 | |
D: GlcNAc | |||
H1 | 4.77 | 4.75 | |
H2 | 3.85 | 3.87 | |
H3 | 3.81 | 3.87 | |
H4 | 3.70 | 3.75 | |
H5 | 3.51 | 3.53 | |
H6′ | 3.93 | 3.95 | |
H6′ | 3.77 | 3.82 | |
NHAc:CH3 | 1.95 | 1.95 | |
Dr: GlcNAc | |||
H1 α/β | 5.18/4.73 | 5.18/4.73 | |
H2 α/β | 4.03/3.80 | 4.03/3.81 | |
H3 α/β | 3.99/3.81 | 4.00/3.81 | |
H4 α/β | 3.75/3.73 | 3.75/3.73 | |
H5 α/β | 3.92/3.52 | 3.93/3.53 | |
H6 α/β | 3.84/3.91 | 3.95/3.82 | |
H6′ | 3.78 | 3.82 | |
NHAc: CH3 | 1.95 | 1.95 |